Page last updated: 2024-08-24

ziprasidone and phenyl acetate

ziprasidone has been researched along with phenyl acetate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freeman, MP; Gelenberg, AJ; Gnanadesikan, M	1
Caldwell, WB; Sagawa, K; Shah, JC; Thombre, AG	1
Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR	1

Reviews

1 review(s) available for ziprasidone and phenyl acetate

Article	Year
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. Bipolar disorders, 2003, Volume: 5, Issue:3 Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid	2003

Article

Year

Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.

Bipolar disorders, 2003, Volume: 5, Issue:3

Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid

2003

Other Studies

2 other study(ies) available for ziprasidone and phenyl acetate

Article	Year
In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations. International journal of pharmaceutics, 2012, May-30, Volume: 428, Issue:1-2 Topics: Absorption; Acetates; Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Cyclodextrins; Dogs; Drug Stability; Fasting; Hypromellose Derivatives; Male; Methylcellulose; Nanoparticles; Particle Size; Piperazines; Solubility; Succinic Acid; Suspensions; Thiazoles	2012
In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone. Drug metabolism letters, 2018, Volume: 12, Issue:2 Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole	2018

Article

Year

In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.

International journal of pharmaceutics, 2012, May-30, Volume: 428, Issue:1-2

Topics: Absorption; Acetates; Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Cyclodextrins; Dogs; Drug Stability; Fasting; Hypromellose Derivatives; Male; Methylcellulose; Nanoparticles; Particle Size; Piperazines; Solubility; Succinic Acid; Suspensions; Thiazoles

2012

In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.

Drug metabolism letters, 2018, Volume: 12, Issue:2

Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole

2018